tiprankstipranks
Trending News
More News >
Solvonis Therapeutics plc (GB:SVNS)
LSE:SVNS
UK Market

Solvonis Therapeutics (SVNS) Income Statement

Compare
12 Followers

Solvonis Therapeutics Income Statement

Last quarter (Q4 2024), Solvonis Therapeutics's total revenue was £0.00, a decrease of -100.00% from the same quarter last year. In Q4, Solvonis Therapeutics's net income was £-335.00K. See Solvonis Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 0.00£ 587.00K£ 542.00K£ 219.00K£ 690.86K
Gross Profit
£ 0.00£ -134.00K£ -51.00K£ 55.00K£ 517.72K
Operating Expenses
£ 1.38M£ 3.26M£ 2.66M£ 900.00K£ 629.14K
Depreciation and Amortization
£ 0.00£ 177.00K£ 113.00K£ 46.00K£ 121.71K
EBITDA
£ -1.38M£ -2.94M£ -2.59M£ -900.00K£ -322.29K
Operating Income
£ -1.38M£ -3.12M£ -2.71M£ -845.00K£ -111.43K
Other Income/Expenses
£ -64.00K£ -3.00K£ -4.00K£ -109.00K£ -162.86K
Pretax Income
£ -1.45M£ -3.12M£ -2.71M£ -954.00K£ -274.29K
Net Income
£ -1.59M£ -3.12M£ -2.71M£ -954.00K£ -274.29K
Per Share Metrics
Basic EPS
£ 0.00£ -0.03£ -0.03£ -0.01£ 0.00
Diluted EPS
£ 0.00£ -0.03£ -0.03£ -0.01£ 0.00
Weighted Average Shares Outstanding
1.16B 104.06M 103.59M 104.10M 104.10M
Weighted Average Shares Outstanding (Diluted)
1.16B 104.06M 103.59M 104.10M 104.10M
Currency in GBP

Solvonis Therapeutics Earnings and Revenue History